r-glucagon

DRUG2 trials

Sponsors

Sanofi

Conditions

Type 1 Diabetes Mellitus

Phase 1

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients

CompletedNCT02625636

SanofiType 1 Diabetes Mellitus

Start: 2015-12-31End: 2016-02-29Updated: 2016-08-23

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

WithdrawnNCT02635243

SanofiType 1 Diabetes Mellitus

Start: 2016-04-30End: 2016-11-30Updated: 2016-09-02